Crossing the E-cadherin-GFP mouse with distinct genetic models of pancreatic cancer has demonstrated its utility for examining the effects of specific mutations on E-cadherin in a time- and tissue-specific and subcellular manner. The gene discussed is CDH1; the disease is familial pancreatic carcinoma.